US Patent

US8524733 — Benzoquinoline inhibitors of vesicular monoamine transporter 2

Composition of Matter · Assigned to Auspex Pharmaceuticals Inc · Expires 2031-04-03 · 5y remaining

Vulnerability score 18/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects new benzoquinoline inhibitors of the vesicular monoamine transporter 2 (VMAT2) and their pharmaceutical compositions.

USPTO Abstract

The present invention relates to new benzoquinoline inhibitors of vesicular monoamine transporter 2 (VMAT2), pharmaceutical compositions thereof, and methods of use thereof.

Drugs covered by this patent

Patent Metadata

Patent number
US8524733
Jurisdiction
US
Classification
Composition of Matter
Expires
2031-04-03
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Auspex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.